Medpace Holdings, Inc. (MEDP)

Market Cap	7.40B
Revenue (ttm)	1.67B
Net Income (ttm)	268.66M
Shares Out	30.56M
EPS (ttm)	8.35
PE Ratio	29.00
Forward PE	26.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	347,853
Open	248.90
Previous Close	246.37
Day's Range	241.49 - 248.94
52-Week Range	149.07 - 282.73
Beta	1.38
Analysts	Buy
Price Target	253.00 (+4.49%)
Earnings Date	Oct 23, 2023

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmac...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 11, 2016
• Employees: 4,500
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDP

Financial Performance

In 2022, MEDP's revenue was $1.46 billion, an increase of 27.80% compared to the previous year's $1.14 billion. Earnings were $245.37 million, an increase of 34.93%.

Analyst Forecast

According to 3 analysts, the average rating for MEDP stock is "Buy." The 12-month stock price forecast is $253.0, which is an increase of 4.49% from the latest price.

Price Target

$253.0

(4.49% upside)

Analyst Consensus: Buy